Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cerebral Palsy, Dyskinetic: full-pipeline trial registry
2 of 3 indexed Cerebral Palsy, Dyskinetic trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Cerebral Palsy, Dyskinetic: 3 US clinical trials tracked, 2 recruiting.
Cerebral Palsy, Dyskinetic is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Mercy Hospital Kansas City, running 1 of these trials.
Enrollment posture brief
Registry condition cerebral-palsy-dyskinetic
OPEN 2 | RECR 67% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Cerebral Palsy, Dyskinetic lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cerebral Palsy, Dyskinetic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cerebral Palsy, Dyskinetic is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
Children's Mercy Hospital Kansas City
NCT06554288
Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
Children's National Research Institute
NCT06036199
A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
Teva Branded Pharmaceutical Products R&D
NCT03813238
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cerebral Palsy, Dyskinetic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cerebral Palsy, Dyskinetic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cerebral Palsy, Dyskinetic page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Cerebral Palsy, Dyskinetic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Mercy Hospital Kansas City sponsors the most Cerebral Palsy, Dyskinetic trials on record, review their full trial history before evaluating a specific study. See Children's Mercy Hospital Kansas City's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cerebral Palsy, Dyskinetic condition card totals 3 registered trials; most-linked intervention TEV-50717; top US site state District of Columbia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.